FDA Inspection 1307906 — Vitalant
The FDA completed an inspection of Vitalant on Mar 12, 2026 in Santa Maria, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 12, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Santa Maria, CA (United States)